Your browser doesn't support javascript.
loading
Improved production of the non-native cofactor F420 in Escherichia coli.
Shah, Mihir V; Nazem-Bokaee, Hadi; Antoney, James; Kang, Suk Woo; Jackson, Colin J; Scott, Colin.
Afiliación
  • Shah MV; Biocatalysis and Synthetic Biology Team, CSIRO Land and Water, Black Mountain Science and Innovation Precinct, Canberra, ACT, Australia.
  • Nazem-Bokaee H; Synthetic Biology Future Science Platform, Black Mountain Science and Innovation Precinct, Canberra, ACT, Australia.
  • Antoney J; Biocatalysis and Synthetic Biology Team, CSIRO Land and Water, Black Mountain Science and Innovation Precinct, Canberra, ACT, Australia.
  • Kang SW; Synthetic Biology Future Science Platform, Black Mountain Science and Innovation Precinct, Canberra, ACT, Australia.
  • Jackson CJ; Synthetic Biology Future Science Platform, Black Mountain Science and Innovation Precinct, Canberra, ACT, Australia.
  • Scott C; Research School of Chemistry, Australian National University, Canberra, ACT, Australia.
Sci Rep ; 11(1): 21774, 2021 11 05.
Article en En | MEDLINE | ID: mdl-34741069
The deazaflavin cofactor F420 is a low-potential, two-electron redox cofactor produced by some Archaea and Eubacteria that is involved in methanogenesis and methanotrophy, antibiotic biosynthesis, and xenobiotic metabolism. However, it is not produced by bacterial strains commonly used for industrial biocatalysis or recombinant protein production, such as Escherichia coli, limiting our ability to exploit it as an enzymatic cofactor and produce it in high yield. Here we have utilized a genome-scale metabolic model of E. coli and constraint-based metabolic modelling of cofactor F420 biosynthesis to optimize F420 production in E. coli. This analysis identified phospho-enol pyruvate (PEP) as a limiting precursor for F420 biosynthesis, explaining carbon source-dependent differences in productivity. PEP availability was improved by using gluconeogenic carbon sources and overexpression of PEP synthase. By improving PEP availability, we were able to achieve a ~ 40-fold increase in the space-time yield of F420 compared with the widely used recombinant Mycobacterium smegmatis expression system. This study establishes E. coli as an industrial F420-production system and will allow the recombinant in vivo use of F420-dependent enzymes for biocatalysis and protein engineering applications.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_zoonosis Asunto principal: Riboflavina Tipo de estudio: Evaluation_studies Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_zoonosis Asunto principal: Riboflavina Tipo de estudio: Evaluation_studies Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Australia
...